554 related articles for article (PubMed ID: 11734856)
1. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression.
Makino Y; Cao R; Svensson K; Bertilsson G; Asman M; Tanaka H; Cao Y; Berkenstam A; Poellinger L
Nature; 2001 Nov; 414(6863):550-4. PubMed ID: 11734856
[TBL] [Abstract][Full Text] [Related]
2. Binding and regulation of hypoxia-inducible factor-1 by the inhibitory PAS proteins.
Jang MS; Park JE; Lee JA; Park SG; Myung PK; Lee DH; Park BC; Cho S
Biochem Biophys Res Commun; 2005 Nov; 337(1):209-15. PubMed ID: 16182248
[TBL] [Abstract][Full Text] [Related]
3. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
4. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
[TBL] [Abstract][Full Text] [Related]
5. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
[TBL] [Abstract][Full Text] [Related]
6. Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia.
Salceda S; Beck I; Caro J
Arch Biochem Biophys; 1996 Oct; 334(2):389-94. PubMed ID: 8900415
[TBL] [Abstract][Full Text] [Related]
7. Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression.
Sato F; Bhawal UK; Kawamoto T; Fujimoto K; Imaizumi T; Imanaka T; Kondo J; Koyanagi S; Noshiro M; Yoshida H; Kusumi T; Kato Y; Kijima H
Genes Cells; 2008 Feb; 13(2):131-44. PubMed ID: 18233956
[TBL] [Abstract][Full Text] [Related]
8. Association of ARNT splice variants with estrogen receptor-negative breast cancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis.
Qin C; Wilson C; Blancher C; Taylor M; Safe S; Harris AL
Clin Cancer Res; 2001 Apr; 7(4):818-23. PubMed ID: 11309328
[TBL] [Abstract][Full Text] [Related]
9. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.
Jiang BH; Agani F; Passaniti A; Semenza GL
Cancer Res; 1997 Dec; 57(23):5328-35. PubMed ID: 9393757
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms.
Damert A; Machein M; Breier G; Fujita MQ; Hanahan D; Risau W; Plate KH
Cancer Res; 1997 Sep; 57(17):3860-4. PubMed ID: 9288800
[TBL] [Abstract][Full Text] [Related]
11. Divergent expression patterns for hypoxia-inducible factor-1beta and aryl hydrocarbon receptor nuclear transporter-2 in developing kidney.
Freeburg PB; Abrahamson DR
J Am Soc Nephrol; 2004 Oct; 15(10):2569-78. PubMed ID: 15466261
[TBL] [Abstract][Full Text] [Related]
12. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT.
Maltepe E; Schmidt JV; Baunoch D; Bradfield CA; Simon MC
Nature; 1997 Mar; 386(6623):403-7. PubMed ID: 9121557
[TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha.
Hara S; Hamada J; Kobayashi C; Kondo Y; Imura N
Biochem Biophys Res Commun; 2001 Oct; 287(4):808-13. PubMed ID: 11573933
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia--a key regulatory factor in tumour growth.
Harris AL
Nat Rev Cancer; 2002 Jan; 2(1):38-47. PubMed ID: 11902584
[TBL] [Abstract][Full Text] [Related]
15. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization and regulation of hypoxia-inducible factor-2alpha in vascular endothelial cells.
Takahashi R; Kobayashi C; Kondo Y; Nakatani Y; Kudo I; Kunimoto M; Imura N; Hara S
Biochem Biophys Res Commun; 2004 Apr; 317(1):84-91. PubMed ID: 15047151
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
18. Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock.
Takahata S; Sogawa K; Kobayashi A; Ema M; Mimura J; Ozaki N; Fujii-Kuriyama Y
Biochem Biophys Res Commun; 1998 Jul; 248(3):789-94. PubMed ID: 9704006
[TBL] [Abstract][Full Text] [Related]
19. [Hypoxia and tumors: does HIF-1 transcription factor favor tumor growth or hypoxia?].
Vandenbunder B
Bull Cancer; 1998 Oct; 85(10):843-5. PubMed ID: 9835861
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of vascular endothelial growth factor in human skeletal muscle in response to short-term one-legged exercise training.
Gustafsson T; Knutsson A; Puntschart A; Kaijser L; Nordqvist AC; Sundberg CJ; Jansson E
Pflugers Arch; 2002 Sep; 444(6):752-9. PubMed ID: 12355175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
